类风湿性关节炎
血栓素A2
氧化代谢
受体
化学
线粒体
信号
内科学
内分泌学
新陈代谢
氧化应激
氧化磷酸化
血栓素受体
药理学
骨重建
医学
关节炎
信号通路
信号转导
破骨细胞
刺猬信号通路
细胞凋亡
癌症研究
能量代谢
血栓素
作者
Liyan Mei,Xin Li,Siyuan Rao,Chunping Bo,Zifeng Chen,Chuangning Li,占晨光,Xingrui Yan,Mengyang Ma,Peng Zhang,Yu Wen,Xiang Guo,Bozheng Chen,Meiqi Chen,Xiaodong Wu,Kaixin Gao,Haifang Du,Huimin Wang,Junao Wang,Tingkai Zhong
标识
DOI:10.1038/s41467-026-78259-5
摘要
Activated platelets contribute to inflammation in rheumatoid arthritis, but how platelet-derived signals promote bone erosion remains poorly understood. Here we show that thromboxane A2, a major mediator released by activated platelets, promotes the formation of bone-resorbing osteoclasts through the thromboxane A2 receptor. Markers of thromboxane A2 biosynthesis are increased in patients with rheumatoid arthritis, while pharmacological inhibition or genetic loss of its receptor suppresses osteoclastogenesis in mouse cells and mice. Integrated molecular analyses reveal that thromboxane A2 receptor signalling supports osteoclastogenesis by increasing fatty acid oxidation and acetyl-coenzyme A supply needed for mitochondrial energy metabolism, involving peroxisome proliferator-activated receptor gamma coactivator 1 beta, peroxisome proliferator-activated receptor gamma and acyl-coenzyme A synthetase long-chain family member 1. In male mice, receptor inhibition or genetic deletion reduces osteoclast accumulation and bone destruction. These findings identify thromboxane A2 signalling as a driver of inflammatory bone erosion and a potential therapeutic target in rheumatoid arthritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI